Relation betwEen Abdominal Aorta and Carotid Artery Responses to SymPathetic stimulatiON uSing duplEx Ultrasound (RESPONSE)

October 9, 2020 updated by: Rijnstate Hospital

Abdominal aortic aneurysm (AAA) is a common vascular disease and associated with risk of rupture, but also with a high cardiovascular (CV) event rate. A key difficulty in AAA is predicting these life-threatening complications. Recent studies suggest that the endothelial function of the abdominal aorta might have a correlation with the disease development. A novel, easy to perform, non-invasive test can assess central artery endothelial function (i.e. the carotid artery reactivity (CAR)). The CAR test is based on the cold pressure test (CPT), which induces sympathetic stimulation by placing one hand in cold water. Using duplex ultrasound, central artery blood flow and diameter responses can be examined.

Previous work has demonstrated that the CPT is associated with an increase in abdominal aortic diameter, whilst others found that the carotid and coronary artery diameter also shows dilation. Interestingly, a previous study found a strong correlation between carotid and coronary artery diameter responses to the CPT, whilst these artery responses show independent prognostic value for future cardiovascular events in patients with peripheral arterial disease. Possibly, similarity may be present in central artery reactivity to the CPT. To date, no study examined whether carotid and aorta responses are in agreement during the CPT. Given the potential importance of central artery vasoreactivity for AAA, the CAR-test may have potential in this group, especially given the relative simplicity of measuring the carotid artery.

The aim of this explorative study is to investigate the correlation between the magnitude of the abdominal aorta and the carotid artery diameter and blood flow responses during the sympathetic stimulation (using the cold pressor test) between healthy young, healthy older and individuals with AAA.

Study Overview

Detailed Description

The present study is an explorative, observational study, which will include in total 60 participants divided over 3 groups; healthy young adults, healthy older adults and patients with a stable abdominal aortic aneurysm (i.e. 30-50 mm), who are currently under threshold for repair. When participants meet the criteria, they will be informed about the study and they will be asked for their written informed consent, when they are willing to participate. Every participant only need to visit one time, which takes approximately 30 minutes. Participant characteristics will be registered, including traditional risk factors and CV history. Subsequently, the investigators will perform the CAR-test, which takes approximately 15 minutes. Prior to the CAR-test, participants should follow some instructions with regard to food and fluid intake according to a physiological guideline, which can influence this test.

Study Type

Observational

Enrollment (Actual)

60

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Gelderland
      • Arnhem, Gelderland, Netherlands
        • Rijnstate Hospital
      • Nijmegen, Gelderland, Netherlands, 6525GA
        • Radboudumc

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

  1. twenty healthy, young (18-40 years) subjects,
  2. twenty older subjects (>60 years) with a small, stable abdominal aortic aneurysm (i.e. AAA diameter of 30-50 mm), and
  3. twenty healthy, age-/sex matched with group 2. We aim to include an equal number of male and females in both groups.

Description

Inclusion Criteria:

  • Young healthy group: Male or female between the age of 18 and 40 years old;
  • Older healthy group: Male or female, which are age-/sex-matched with the AAA patients group;
  • AAA patients group: Male or female with an abdominal aortic aneurysm who is still under surveillance, with a diameter between 3.0 and 5.0 cm and at least 18 years old. These patients may participate in the 1-2-3 Trial, which is a similar approved investigation by CMO region Arnhem-Nijmegen with registration number 2019-5216.
  • Informed consent form understood and signed;

Exclusion Criteria:

  • Psychiatric or other conditions that may interfere with the study;
  • Participating in another clinical study, interfering on outcomes;
  • With regard to the necessary quality of the ultrasound images, BMI ≥ 30 kg/m2;
  • Increased risk for coronary spasms (score Rose-questionnaire ≥2; this questionnaire can be found in the Appendix);
  • Known carotid artery disease
  • Presence of Raynaud's phenomenon, Marfan syndrome, chronic pain syndrome at upper extremity(s), presence of an AV fistula or shunt, open wounds to the upper extremity(s), and/or scleroderma associated with placing the hand in ice water;
  • Recent (<3 months) presence of angina pectoris, myocardial infarction, cerebral infarction, and/or heart failure, or PAD treatment.
  • Healthy groups:

    • Systolic blood pressure >140 and/or diastolic blood pressure >90
    • Cardiovascular history
    • Antihypertensive medication

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
1. Young healthy group
Male or female between the age of 18 and 40 years old. No presence of systolic blood pressure >140 and/or diastolic blood pressure >90, cardiovascular history or antihypertensive medication
The CAR test will be applied to stimulate the sympathetic nervous system. This thermal stimulus is known to elevate blood pressure via sympathetic pathways, so it can be used to study the vascular response to sympathetic activation. The participant will submerge their left hand in a bucket of ice water (approximately 4 degrees celcius) for 3 minutes, which is reported to be sufficient to induce a maximal dilation in the common carotid artery. At baseline and every minute after the hand is submerged in ice water, the blood pressure will be measured to check whether a sympathetic stimulation is achieved. During this test as well the carotid artery as the abdominal aorta will be visualized using ultrasound.
2. Patients with an AAA
Individuals (>60 years) with a small, stable, abdominal aortic aneurysm (i.e. AAA diameter of 30-50 mm)
The CAR test will be applied to stimulate the sympathetic nervous system. This thermal stimulus is known to elevate blood pressure via sympathetic pathways, so it can be used to study the vascular response to sympathetic activation. The participant will submerge their left hand in a bucket of ice water (approximately 4 degrees celcius) for 3 minutes, which is reported to be sufficient to induce a maximal dilation in the common carotid artery. At baseline and every minute after the hand is submerged in ice water, the blood pressure will be measured to check whether a sympathetic stimulation is achieved. During this test as well the carotid artery as the abdominal aorta will be visualized using ultrasound.
3. Healthy older group
Healthy age- and sex- matched with group 2 with no presence of systolic blood pressure >140 and/or diastolic blood pressure >90, cardiovascular history or antihypertensive medication
The CAR test will be applied to stimulate the sympathetic nervous system. This thermal stimulus is known to elevate blood pressure via sympathetic pathways, so it can be used to study the vascular response to sympathetic activation. The participant will submerge their left hand in a bucket of ice water (approximately 4 degrees celcius) for 3 minutes, which is reported to be sufficient to induce a maximal dilation in the common carotid artery. At baseline and every minute after the hand is submerged in ice water, the blood pressure will be measured to check whether a sympathetic stimulation is achieved. During this test as well the carotid artery as the abdominal aorta will be visualized using ultrasound.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
CAR-test
Time Frame: Baseline
Percentage of vasodilation/vasoconstriction to the CAR test at the common carotid artery
Baseline
CAR-test
Time Frame: Baseline
Percentage of vasodilation/vasoconstriction to the CAR test at the abdominal aorta
Baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
CAR-test
Time Frame: Baseline
Magnitude of the blood flow and perfusion response of the carotid artery
Baseline
CAR-test
Time Frame: Baseline
Timing of the blood flow and perfusion response of the carotid artery
Baseline
CAR-test
Time Frame: Baseline
Magnitude of the blood flow and perfusion response of the abdominal aorta
Baseline
CAR-test
Time Frame: Baseline
Timing of the blood flow and perfusion response of the abdominal aorta
Baseline
CAR-test
Time Frame: Baseline
Blood pressure response
Baseline
CAR-test
Time Frame: Baseline
Heart rate response
Baseline
Age
Time Frame: Baseline
Age
Baseline

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Demographic characteristics
Time Frame: Baseline
Gender
Baseline
Demographic characteristics
Time Frame: Baseline
If current smoker
Baseline
Demographic characteristics
Time Frame: Baseline
Height
Baseline
Demographic characteristics
Time Frame: Baseline
Weight
Baseline
Demographic characteristics
Time Frame: Baseline
Medical history
Baseline
Demographic characteristics
Time Frame: Baseline
Blood pressure
Baseline
Demographic characteristics
Time Frame: Baseline
Heart rate
Baseline
Medication use
Time Frame: Baseline
Ask about: Statins
Baseline
Medication use
Time Frame: Baseline
Ask about: Beta-blockers
Baseline
Medication use
Time Frame: Baseline
Ask about: Sympathicomimetica
Baseline
Medication use
Time Frame: Baseline
Ask about: Anti-platelets
Baseline
Medication use
Time Frame: Baseline
Ask about: Anti-coagulants
Baseline
Medication use
Time Frame: Baseline
Ask about: Anti-hypertensives (questioned)
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Michel Reijnen, MD, prof, Rijnstate Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2019

Primary Completion (Actual)

August 1, 2020

Study Completion (Actual)

October 5, 2020

Study Registration Dates

First Submitted

July 25, 2019

First Submitted That Met QC Criteria

July 25, 2019

First Posted (Actual)

July 29, 2019

Study Record Updates

Last Update Posted (Actual)

October 12, 2020

Last Update Submitted That Met QC Criteria

October 9, 2020

Last Verified

October 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Abdominal Aortic Aneurysm

Clinical Trials on Carotid artery reactivity test (CAR-test)

3
Subscribe